Source - RNS
RNS Number : 1239J
InnovaDerma PLC
07 September 2016
 

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO, THE UNITED STATES, CANADA, JAPAN, SOUTH AFRICA, SINGAPORE, HONG KONG OR AUSTRALIA OR ANY OTHER JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION.

This announcement is an advertisement and not a prospectus or supplementary prospectus. Neither this announcement nor anything contained herein shall form the basis of, or be relied upon in connection with, any offer or commitment or invitation to purchase, otherwise acquire, issue, subscribe for, sell or otherwise dispose of any securities whatsoever in any jurisdiction. Investors should not purchase or subscribe for any transferable securities referred to in this announcement except on the basis of information contained in the Prospectus and Supplementary Prospectus in their final forms published by InnovaDerma PLC in connection with the admission of the Company's ordinary shares to the Official List of the UK Listing Authority and to trading on the main market for listed securities of London Stock Exchange plc.

 

InnovaDerma PLC

Admission to the Official List and to trading on the Main Market of the London Stock Exchange

 

InnovaDerma PLC (the "Company"), a UK developer of 'at-home' and clinically-proven treatments for hair loss, hair care, self-tanning and skin rejuvenation today announces that its entire issued share capital consisting of 10,318,535 ordinary shares of €0.10 each (the "Ordinary Shares") will today be admitted to the standard segment of the Official List of the UK Listing Authority and to trading on the Main Market for listed securities of the London Stock Exchange (together "Admission"). Dealings are expected to commence at 8:00 a.m. under the TIDM code "IDP" (ISIN: GBOOBT9PTW34).  The Ordinary Shares already trade under the TIDM code "MLIDP" on the Marché Libre operated by Euronext Paris SA. It is the Company's intention to delist its Ordinary Shares from the Marché Libre.

 

The Prospectus and Supplementary Prospectus published by the Company on 25 July 2016 and on 2 September 2016, respectively, in connection with this Admission can be found on the Company's website at www.innovadermaplc.com.

 

Mr. Haris Chaudhry, Executive Chairman and Founder of InnovaDerma said:

 

"With our strong brands, which have an international presence, and the excellent progress made by the Group, the opportunities that lie ahead make this an exciting time for us to bring InnovaDerma to the London Stock Exchange."

 

Further enquiries

 

InnovaDerma

Haris Chaudhry/Joe Bayer

 

 

+61 (0)3 9111 0071

Sole broker

Hybridan LLP

Claire Noyce/Niall Pearson

 

+44 (0)203 764 2341 / 2343

Cardew Group

Shan Shan Willenbrock

David Roach

Emma Ruttle

 

 

+44 (0)20 7930 0777

 

About InnovaDerma:

InnovaDerma PLC specialises in the research, manufacture and marketing of clinically proven products in hair loss, anti-ageing and beauty sectors. InnovaDerma has presence in the United Kingdom, Australia, New Zealand, Philippines, South Africa, Hong Kong and South Korea.

 

www.innovadermaplc.com

 

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
LISQQLFBQKFBBBZ

Related Charts

Innovaderma (IDP)

+19.50p (+14.08%)
delayed 18:15PM